- Home
- ITIC vs VALN Comparison
ITIC vs VALN Comparison
Compare ITIC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- VALN
- Stock Information
- Founded
- ITIC 1972
- VALN 2012
- Country
- ITIC United States
- VALN France
- Employees
- ITIC N/A
- VALN N/A
- Industry
- ITIC Specialty Insurers
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITIC Finance
- VALN Health Care
- Exchange
- ITIC Nasdaq
- VALN Nasdaq
- Market Cap
- ITIC 437.8M
- VALN 510.7M
- IPO Year
- ITIC N/A
- VALN 2021
- Fundamental
- Price
- ITIC $240.98
- VALN $6.39
- Analyst Decision
- ITIC
- VALN Strong Buy
- Analyst Count
- ITIC 0
- VALN 3
- Target Price
- ITIC N/A
- VALN $15.33
- AVG Volume (30 Days)
- ITIC 14.0K
- VALN 12.7K
- Earning Date
- ITIC 05-08-2025
- VALN 05-07-2025
- Dividend Yield
- ITIC 6.44%
- VALN N/A
- EPS Growth
- ITIC 18.56
- VALN N/A
- EPS
- ITIC 15.69
- VALN N/A
- Revenue
- ITIC $261,183,000.00
- VALN $201,099,222.00
- Revenue This Year
- ITIC N/A
- VALN $17.98
- Revenue Next Year
- ITIC N/A
- VALN $26.61
- P/E Ratio
- ITIC $15.37
- VALN N/A
- Revenue Growth
- ITIC 15.26
- VALN 21.64
- 52 Week Low
- ITIC $146.41
- VALN $3.62
- 52 Week High
- ITIC $290.40
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- ITIC 57.98
- VALN 44.86
- Support Level
- ITIC $234.99
- VALN $6.18
- Resistance Level
- ITIC $245.00
- VALN $6.55
- Average True Range (ATR)
- ITIC 4.54
- VALN 0.30
- MACD
- ITIC 1.09
- VALN -0.02
- Stochastic Oscillator
- ITIC 84.20
- VALN 19.37
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.